We are committed to participating in clinical trials that offer promising treatment options for our patients.
Our hope is that our efforts may contribute to patients gaining new knowledge regarding breast cancer. Our research activities are coordinated through the Ridley-Tree Cancer Center and UCLA Health.
For more information on open clinical research studies
at the Ridley-Tree Cancer Center, click below:
Get in touch with the RTCC research team:
(805) 879-0643
For more information on open clinical research studies
at UCLA Health, click below:
A Dose-escalation, Expansion Study of ARX788, in Advanced Solid Tumors Subjects With HER2 Expression (ACE-Pan Tumor 01)
Status: Open, Actively Recruiting
A Study of Zanidatamab (ZW25) With Evorpacept (ALX148) in Patients With Advanced HER2-expressing Cancer
Status: Open, Actively Recruiting
Trilaciclib in Patients Receiving Sacituzumab Govitecan-hziy for Triple Negative Breast Cancer
Status: Open, Actively Recruiting
Get in touch with the UCLA research team: